Found: 408
Select item for more details and to access through your institution.
A novel stability‐indicating analytical method development for simultaneous determination of carboplatin and decitabine from nanoparticles.
- Published in:
- Journal of Separation Science, 2020, v. 43, n. 17, p. 3491, doi. 10.1002/jssc.202000320
- By:
- Publication type:
- Article
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5047, doi. 10.1007/s00432-022-04436-w
- By:
- Publication type:
- Article
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 12, p. 3089, doi. 10.1007/s00432-019-03031-w
- By:
- Publication type:
- Article
Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 329, doi. 10.1007/s00432-018-2790-6
- By:
- Publication type:
- Article
Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 8, p. 1371, doi. 10.1007/s00432-017-2394-6
- By:
- Publication type:
- Article
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 873, doi. 10.1007/s00432-016-2331-0
- By:
- Publication type:
- Article
Application of RP-HPLC method for stability study and quantifying decitabine in bulk drug and in pharmaceutical dosage form.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 4, p. 261, doi. 10.31838/ijpr/2020.12.04.064
- By:
- Publication type:
- Article
地西他滨单药及联合半程和全程HA方案治疗骨髓增生异常综合征和急性髓系白血病的效果.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 1, p. 150, doi. 10.13241/j.cnki.pmb.2021.01.033
- By:
- Publication type:
- Article
The therapeutic effect of decitabine combined with HAG in acute myeloid leukemia: a retrospective case-control analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 23, p. 11334
- By:
- Publication type:
- Article
Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/1985750
- By:
- Publication type:
- Article
DNA DEMETHYLATING AGENTS SENSITIZE IMMUNE‐BASED CYTOTOXICITY BY UPREGULATING IMMUNE SYNAPSE MOLECULES ON LUNG CANCER CELLS.
- Published in:
- Respirology, 2018, v. 23, p. 170, doi. 10.1111/resp.13420_227
- Publication type:
- Article
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome.
- Published in:
- Systematic Reviews, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s13643-018-0805-7
- By:
- Publication type:
- Article
Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1134895
- By:
- Publication type:
- Article
Traditional Chinese Medicine: A Class of Potentially Reliable Epigenetic Drugs.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.907031
- By:
- Publication type:
- Article
Influence of histone deacetylase inhibitors and DNA-methyltransferase inhibitors on the NK cell-mediated lysis of pediatric B-lineage leukemia.
- Published in:
- Frontiers in Oncology, 2013, p. 1, doi. 10.3389/fonc.2013.00099
- By:
- Publication type:
- Article
Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation.
- Published in:
- Frontiers in Genetics, 2021, v. 11, p. N.PAG, doi. 10.3389/fgene.2020.603956
- By:
- Publication type:
- Article
Decitabine bioproduction using a biocatalyst with improved stability by adding nanocomposites.
- Published in:
- AMB Express, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13568-020-01109-0
- By:
- Publication type:
- Article
Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15<sup>INK4B</sup> promoter demethylation in myelodysplastic syndrome.
- Published in:
- Gene Therapy, 2015, v. 22, n. 4, p. 287, doi. 10.1038/gt.2015.1
- By:
- Publication type:
- Article
Systematic characterization of cancer transcriptome at transcript resolution.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34568-z
- By:
- Publication type:
- Article
Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 425, doi. 10.3390/ph17040425
- By:
- Publication type:
- Article
NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer.
- Published in:
- Pharmaceuticals (14248247), 2018, v. 11, n. 2, p. 36, doi. 10.3390/ph11020036
- By:
- Publication type:
- Article
Valency-Based Indices for Some Succinct Drugs by Using M-Polynomial.
- Published in:
- Symmetry (20738994), 2023, v. 15, n. 3, p. 603, doi. 10.3390/sym15030603
- By:
- Publication type:
- Article
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0411-x
- By:
- Publication type:
- Article
PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01565-3
- By:
- Publication type:
- Article
Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0607-3
- By:
- Publication type:
- Article
Existence of multiple organ aging in animal model of emphysema induced by cigarette smoke extract.
- Published in:
- Tobacco Induced Diseases, 2022, v. 20, p. 1, doi. 10.18332/tid/143853
- By:
- Publication type:
- Article
Cigarette smoke extract affects methylation status and attenuates Sca-1 expression of mouse endothelial progenitor cell in vitro.
- Published in:
- Tobacco Induced Diseases, 2021, v. 19, p. 1, doi. 10.18332/tid/131625
- By:
- Publication type:
- Article
Inhibiting DNA methylation alleviates cigarette smoke extract-induced dysregulation of Bcl-2 and endothelial apoptosis.
- Published in:
- Tobacco Induced Diseases, 2020, v. 18, p. 1
- By:
- Publication type:
- Article
Inqovi First Oral Hypomethylating Agent Approved for Intermediateor High-Risk Myelodysplastic Syndromes.
- Published in:
- American Health & Drug Benefits, 2020, v. 13, p. 20
- Publication type:
- Article
Decitabine for Acute Myeloid Leukemia in a Patient Undergoing Hemodialysis.
- Published in:
- European Journal of Inflammation, 2011, v. 9, n. 3, p. 289, doi. 10.1177/1721727X1100900310
- By:
- Publication type:
- Article
Mixed Phenotype Acute Leukemia that Evolved from Myelodysplastic Syndrome with Excess Blasts.
- Published in:
- Laboratory Medicine, 2020, v. 51, n. 3, p. 288, doi. 10.1093/labmed/lmz054
- By:
- Publication type:
- Article
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 6, p. 849, doi. 10.1111/ijlh.13299
- By:
- Publication type:
- Article
Chronic myelomonocytic leukaemia: leukaemia cutis predicts disease progression.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Psychotropic drug use and suggestive depression symptoms associated with NR3C1 DNA methylation.
- Published in:
- Revista Brasileira de Crescimento e Desenvolvimento Humano, 2023, v. 33, n. 1, p. 139, doi. 10.36311/jhgd.v33.14300
- By:
- Publication type:
- Article
Decitabine Treatment Induces a Viral Mimicry Response in Cervical Cancer Cells and Further Sensitizes Cells to Chemotherapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14042, doi. 10.3390/ijms232214042
- By:
- Publication type:
- Article
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3815, doi. 10.3390/ijms23073815
- By:
- Publication type:
- Article
Extended Prophylactic Effect of N-Tert-Butyl-α-Phenylnitron against Oxidative/Nitrosative Damage Caused by the DNA-Hypomethylating Drug 5-Azacytidine in the Rat Placenta.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 603, doi. 10.3390/ijms23020603
- By:
- Publication type:
- Article
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10232, doi. 10.3390/ijms221910232
- By:
- Publication type:
- Article
S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3721, doi. 10.3390/ijms21103721
- By:
- Publication type:
- Article
Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 40, doi. 10.3390/ijms19010040
- By:
- Publication type:
- Article
The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1606, doi. 10.3390/ijms18081606
- By:
- Publication type:
- Article
Clippings.
- Published in:
- 2022
- By:
- Publication type:
- Announcement
Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of epigallocatechin‐3‐gallate on the status of DNA methylation of E‐cadherin promoter region on endometriosis mouse.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2020, v. 46, n. 10, p. 2076, doi. 10.1111/jog.14358
- By:
- Publication type:
- Article
A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 8, p. 7031, doi. 10.1007/s00520-022-07126-y
- By:
- Publication type:
- Article
The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine.
- Published in:
- Biochemical Journal, 2016, v. 473, n. 17, p. 2635, doi. 10.1042/BCJ20160302
- By:
- Publication type:
- Article
Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 134, doi. 10.3390/jcm9010134
- By:
- Publication type:
- Article
Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report.
- Published in:
- Journal of Immunology Research, 2014, p. 1, doi. 10.1155/2014/371087
- By:
- Publication type:
- Article
Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36872-0
- By:
- Publication type:
- Article